Management of type 2 diabetes in chronic kidney disease by Salim S Virani, Sankar D Navaneethan, Jefferson L Triozzi, L Parker Gregg

Get full text

A Systematic Review and Meta-Analysis of Depression and Protein–Energy Wasting in Kidney Disease by L. Parker Gregg, Thomas Carmody, Dustin Le, Gerard Martins, Madhukar Trivedi, S. Susan Hedayati

Get full text

Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes by L. Parker Gregg, Beverley Adams‐Huet, Xilong Li, Gates Colbert, Nishank Jain, James A. de Lemos, S. Susan Hedayati

Get full text

Using dipstick urinalysis to predict development of acute kidney injury in patients with COVID-19 by Meredith C. McAdams, Michael Li, Pin Xu, L. Parker Gregg, Jiten Patel, Duwayne L. Willett, Ferdinand Velasco, Christoph U. Lehmann, S. Susan Hedayati

Get full text

Risk Prediction for Acute Kidney Injury in Patients Hospitalized With COVID-19Plain-Language Summary by Meredith C. McAdams, Pin Xu, Sameh N. Saleh, Michael Li, Mauricio Ostrosky-Frid, L. Parker Gregg, Duwayne L. Willett, Ferdinand Velasco, Christoph U. Lehmann, S. Susan Hedayati

Get full text

Improving chronic kidney disease detection and treatment in the United States: the chronic kidney disease cascade of care (C3) study protocol by Julio A. Lamprea-Montealegre, Priya Joshi, Abigail S. Shapiro, Erin Madden, Krista Navarra, O. Alison Potok, L. Parker Gregg, Tanya Podchiyska, Amy Robinson, Mary K. Goldstein, Carmen A. Peralta, Simerjot K. Jassal, Sankar D. Navaneethan, Dena. E. Rifkin, Virginia Wang, Michael G. Shlipak, Michelle M. Estrella

Get full text